Measles Vaccine Kills 15 Children in South Sudan
The World Health Organization (WHO) reported on June 1, 2017 that 15 children in the village of Nachodokopele, South Sudan died following receiving the live attenuated virus measles vaccine. The WHO attributed the deaths to “severe sepsis/toxicity resulting from the administration…
Gelatin in Vaccines Can Cause Allergic Reactions
The substance known as “gelatin” is a protein usually obtained from cows or pigs and produced by the partial hydrolysis of collagen extracted by boiling animal parts such as cartilage, tendons, skin, bones and ligaments in water. It acts a stabilizer, thickener and texturizer in food products such as yogurt, cream cheese, ice cream, marshmallows, etc.
Babies in India Die After Getting JE and MMR Vaccines
Two babies died in northeastern India following vaccination against Japanese encephalitis (JE) and measles, mumps and rubella (MMR) at a health center in the village of Patori, Bihar state on the morning of May 5, 2017. Raja Babu Kumar, who was nine months old, and Sonu Kumar, one and half years old, died early the next day.
Girls in South Africa Seriously Ill After Getting HPV Vaccine
Zanrie Nieuwoudt, 11, of Nelspriut, South Africa received the human papillomavirus (HPV) vaccine Gardasil at her school in March and September 2016.1 In December 2016, Zanrie began experiencing migraines, fatigue, dizziness and nausea.2 In January 2016, she suffered pain in both knees. Zanrie underwent MRI scans and blood tests which came back as “normal.” She was flown to…
A Vaccine to Cure Acne?
Acne, one of the more universal causes of teenage angst, affects many adults as well. A chronic inflammatory disease condition, the role of inflammation in the pathology of acne has been confirmed but there are questions about exactly how and why some people develop severe types of acne and others do not. Some researchers believe the chronic inflammatory skin condition may…
The Upcoming Trials for the First Malaria Vaccine
The World Health Organization (WHO) announced on Apr. 24, 2017 that it will conduct field trials in Ghana, Kenya, and Malawi next year on the world’s first malaria vaccine. The vaccine, known as RTS,S (Mosquirix), was developed by GlaxoSmithKline (GSK) of the United Kingdom. It is a injectable vaccine that reportedly offers partial protection against malaria in young children.